USD 0.01
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -708.63 Thousand | -841.99 Thousand | -1.01 Million | -643.1 Thousand | -426.08 Thousand |
Net Income | -3.19 Million | -4.04 Million | -19.79 Million | -1.89 Million | -470.29 Thousand |
Depreciation & Amortization | 13.5 Thousand | 34.24 Thousand | 35.8 Thousand | 1.05 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 1.03 Million | 55.13 Thousand | 806.04 Thousand | 186.91 Thousand | 30.14 Thousand |
Change in working capital | -17.43 Thousand | -608.00 | -1156.00 | 4052.00 | 3686.00 |
Other non-cash items | 1.45 Million | 3.11 Million | 17.94 Million | 1246.00 | 10.37 Thousand |
Investing Cash Flow | -1.92 Million | -745.39 Thousand | -13.98 Million | -762.75 Thousand | -9095.00 |
Investments in PPE | -1.92 Million | -319.44 Thousand | -288.35 Thousand | -205.25 Thousand | -9095.00 |
Acquisitions | - | -40 Thousand | -59.61 Thousand | -1 Million | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | - | -385.95 Thousand | -13.63 Million | 450 Thousand | - |
Financing Cash Flow | 1.22 Million | 3.42 Million | 15 Million | 2.6 Million | 559.57 Thousand |
Debt repayment | -66 Thousand | -36 Thousand | -36 Thousand | -27 Thousand | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | -244.39 Thousand | -472.17 Thousand | -170.39 Thousand | -40.42 Thousand |
Common Stock Issuance | - | 3.7 Million | 15.51 Million | 2.8 Million | 600 Thousand |
Other Financing Activities | 1.29 Million | -36 Thousand | -36 Thousand | -27 Thousand | 559.57 Thousand |
Accounts receivables | -17.43 Thousand | - | - | 5000.00 | -5000.00 |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | - | -608.00 | -1156.00 | -948.00 | 8686.00 |
Cash at beginning of period | 3.45 Million | 1.61 Million | 1.6 Million | 405.14 Thousand | 280.75 Thousand |
Cash at end of period | 2.04 Million | 3.45 Million | 1.61 Million | 1.6 Million | 405.14 Thousand |
Capital Expenditure | -1.92 Million | -319.44 Thousand | -288.35 Thousand | -205.25 Thousand | -9095.00 |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -1.4 Million | 1.83 Million | 11.1 Thousand | 1.19 Million | 124.38 Thousand |
Free Cash Flow | -2.63 Million | -1.16 Million | -1.3 Million | -848.36 Thousand | -435.18 Thousand |
Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -934.95 | -934.95 | -660.57 | -660.57 | -1733.73 | -4.04 Million |
Depreciation & Amortization | 6.75 | 6.75 | - | - | 8.60 | 34.24 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 380.88 | 380.88 | 135.00 | 135.00 | 7.90 | 55.13 Thousand |
Change in working capital | -8.72 | -8.72 | - | - | -0.30 | -608.00 |
Other non-cash items | 483.65 | 483.65 | 243.63 | 243.63 | 1537.60 | 3.11 Million |
Investing Cash Flow | -441.25 | -441.25 | -521.90 | -521.90 | -96.84 | -745.39 Thousand |
Investments in PPE | -441.25 | -441.25 | -521.90 | -521.90 | -76.79 | -319.44 Thousand |
Acquisitions | - | - | - | - | - | -40 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | -20.05 | -385.95 Thousand |
Financing Cash Flow | 638.20 | 638.20 | -25.65 | -25.65 | 1396.62 | 3.42 Million |
Debt repayment | - | - | - | - | - | -36 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | -244.39 Thousand |
Common Stock Issuance | - | - | - | - | - | 3.7 Million |
Other Financing Activities | 638.20 | 638.20 | -25.65 | -25.65 | 1396.62 | -36 Thousand |
Accounts receivables | -8.72 | -8.72 | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | -0.30 | -608.00 |
Cash at beginning of period | - | - | - | - | - | 1.61 Million |
Cash at end of period | 124.57 | 124.57 | -829.49 | -829.49 | 1119.83 | 3.45 Million |
Capital Expenditure | -441.25 | -441.25 | -521.90 | -521.90 | -76.79 | -319.44 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 124.57 | 124.57 | -829.49 | -829.49 | 1119.83 | 1.83 Million |
Free Cash Flow | -513.63 | -513.63 | -803.83 | -803.83 | -256.74 | -1.16 Million |
BROOKS
GB00BL9YR756
3249
BOD
RESONANCE
ISOP